The United States Food and Drug Administration’s staff endorsed the Johnson & Johnson single shot coronavirus vaccine for emergency use authorization on Wednesday following a detailed analysis of the jab.
The FDA’s vaccine advisers are set to meet on Friday to discuss recommending the vaccine for emergency use authorization, after which it is expected the agency will give it the green light promptly.
The vaccine developed by J&J was found to be 72% effective in US clinical trials and 85% effective in preventing severe disease across all regions where it was tested. The vaccine would be the third to be approved for use in the US, following the FDA’s approval of the Pfizer/BioNTech and Moderna jabs.
A joint patrol of the intelligence units of the Nabeul National Guard district and the…
In search of first place in the CAF Champions League final since 2019, Esperance sucedded…
President and Director General of the Export Promotion Center (CEPEX), Mourad Ben Hussein, confirmed that…
Agents from the National Security station in Msaken, and the emergency police patrol in Sousse…
An agreement was inked this Thursday, April 25, between the Ministry of Education and the…
In total, 57 low-income families in special situations were approved for the launch of…
This website uses cookies.